Project Number 1R43AG063560-01 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for DYRK1A inhibitors as therapeutic approach to Tau hyper-phosphorylation for treatment of Alzheimer disease and other CNS disorders Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator ARALDI, GIAN LUCA Principal Investigator First Name GIAN LUCA Principal Investigator Last Name ARALDI Awardee Organization AVANTI BIOSCIENCES, INC. Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-574: PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) FY Overall Cost $449,436 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
